W Health Ventures has announced the launch of its second fund, a $70 million vehicle aimed at driving company creation in India’s fast-evolving healthcare sector.
Operating through a venture studio model in collaboration with 2070 Health, the fund is set to support 8–10 startups over the next four years. The initiative will focus on building scalable, category-defining healthcare companies from the ground up, with a particular emphasis on single-specialty care and AI-led B2B healthcare services.
As India’s $370 billion healthcare market undergoes major structural shifts, W Health aims to plug critical white spaces by combining clinical expertise, startup infrastructure, and strategic capital. The firm has already begun deploying funds, with EverHope Oncology—a cancer care startup—securing a $10 million day-zero investment led by Narayana Health.
“With Fund II, our goal is to create high-impact ventures that solve real pain points across the healthcare landscape,” said a spokesperson from W Health Ventures. “We’re doubling down on company creation in areas where conventional venture models have limitations.”
W Health Ventures has previously backed startups like Wysa, BeatO, Mylo, and Reveal HealthTech. The firm operates in a competitive ecosystem alongside healthcare-focused investors such as HealthQuad, Lightrock, and Fireside Ventures.
The new fund underscores growing investor confidence in India’s healthcare innovation space, as digital health, specialty care, and tech-enabled platforms reshape the future of patient care and health delivery.
